Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Shepherd

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.
Bone Marrow Transplantation|October 21, 2000
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myelomaD E Reece, D A Brockington, G L Phillips, et al.
Bone Marrow Transplantation|January 1, 1994
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesH G Klingemann, J D Shepherd, D E Reece, et al.
Biotechnology Therapeutics|January 1, 1994
Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's diseaseH G Klingemann, K Wilkie-Boyd, A Rubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancyG L Phillips, J D Shepherd, M J Barnett, et al.
British Journal of Cancer|September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumoursM J Barnett, C M Coppin, N Murray, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1990
Recombinant GM-CSF in patients with poor graft function after bone marrow transplantationH G Klingemann, A C Eaves, M J Barnett, et al.
Leukemia & Lymphoma|October 1, 1995
Acute monocytic leukemia: a single institution experienceH Fung, J D Shepherd, S C Naiman, et al.
Bone Marrow Transplantation|October 19, 2004
Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantationJ Kuruvilla, D L Forrest, J C Lavoie, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|May 1, 1992
Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantationT J Nevill, M H Tirgan, H J Deeg, et al.
Blood|December 15, 1991
Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]H G Klingemann, A P Grigg, K Wilkie-Boyd, et al.
Bone Marrow Transplantation|October 21, 2000
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myelomaD E Reece, D A Brockington, G L Phillips, et al.
Bone Marrow Transplantation|January 1, 1994
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategiesH G Klingemann, J D Shepherd, D E Reece, et al.
Biotechnology Therapeutics|January 1, 1994
Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's diseaseH G Klingemann, K Wilkie-Boyd, A Rubin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancyG L Phillips, J D Shepherd, M J Barnett, et al.
British Journal of Cancer|September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumoursM J Barnett, C M Coppin, N Murray, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|April 1, 1990
Recombinant GM-CSF in patients with poor graft function after bone marrow transplantationH G Klingemann, A C Eaves, M J Barnett, et al.
Leukemia & Lymphoma|October 1, 1995
Acute monocytic leukemia: a single institution experienceH Fung, J D Shepherd, S C Naiman, et al.
Bone Marrow Transplantation|October 19, 2004
Characteristics and outcome of patients developing endocarditis following hematopoietic stem cell transplantationJ Kuruvilla, D L Forrest, J C Lavoie, et al.
Pageof 8